Federated Hermes
ALLO icon

Federated Hermes’s Allogene Therapeutics ALLO Stock Holding History

Federated Hermes’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,828
Closed -$17.3K – 2061
2025
Q1 		$17.3K Sell
11,828
-11,543
-49% -$21.8K ﹤0.01% 1746
2024
Q4 		$49.8K Buy
23,371
+3,640
+18% +$8.98K ﹤0.01% 1665
2024
Q3 		$55.2K Buy
19,731
+7,431
+60% +$19.8K ﹤0.01% 1639
2024
Q2 		$28.7K Buy
+12,300
New +$36.3K ﹤0.01% 1683
2023
Q3 		– Sell
-170
Closed -$845 – 2092
2023
Q2 		$845 Hold
170
– – ﹤0.01% 2031
2023
Q1 		$840 Sell
170
-273,683
-100% -$1.76M ﹤0.01% 2052
2022
Q4 		$1.72M Buy
273,853
+273,810
+636,767% +$2.53M ﹤0.01% 959
2022
Q3 		$1K Hold
43
– – ﹤0.01% 2003
2022
Q2 		$1K Sell
43
-58,650
-100% -$521K ﹤0.01% 2019
2022
Q1 		$535K Buy
+58,693
New +$611K ﹤0.01% 1436
2021
Q1 		– Sell
-16,044
Closed -$405K – 2215
2020
Q4 		$405K Sell
16,044
-68,044
-81% -$2.22M ﹤0.01% 1567
2020
Q3 		$3.17M Sell
84,088
-33,619
-29% -$1.27M 0.01% 849
2020
Q2 		$5.04M Buy
+117,707
New +$4.26M 0.01% 712
2019
Q2 		– Sell
-175,000
Closed -$5.06M – 2159
2019
Q1 		$5.06M Hold
175,000
– – 0.01% 787
2018
Q4 		$4.71M Buy
+175,000
New +$4.65M 0.01% 747

Other funds holding ALLO

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federated Hermes's ALLO Position: Q2 2025 in Review

Federated Hermes sold out of Allogene Therapeutics (ALLO) in Q2 2025, closing a stake of 11,828 shares — an estimated $17.3K sold.

Federated Hermes first reported a position in ALLO in Q4 2018 and held it in 15 quarters. The position peaked at $5.06M in Q1 2019. 158 funds tracked by Wall St. Rank hold ALLO as of Q2 2025.

  • Federated Hermes reported no remaining Allogene Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 11,828 Allogene Therapeutics shares in Q2 2025, an estimated $17.3K.
  • Federated Hermes first reported a position in Allogene Therapeutics in Q4 2018 and held it in 15 quarters.
  • Federated Hermes's Allogene Therapeutics position peaked at $5.06M in Q1 2019.
  • 158 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.